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Abstract
Study design Economic modelling analysis.
Objectives To determine lifetime direct and indirect costs from initial hospitalisation of all expected new traumatic and non-
traumatic spinal cord injuries (SCI) over 12 months.
Setting United Kingdom (UK).
Methods Incidence-based approach to assessing costs from a societal perspective, including immediate and ongoing health,
rehabilitation and long-term care directly attributable to SCI, as well as aids and adaptations, unpaid informal care and
participation in employment. The model accounts for differences in injury severity, gender, age at onset and life expectancy.
Results Lifetime costs for an expected 1270 new cases of SCI per annum conservatively estimated as £1.43 billion (2016
prices). This equates to a mean £1.12 million (median £0.72 million) per SCI case, ranging from £0.47 million (median
£0.40 million) for an AIS grade D injury to £1.87 million (median £1.95 million) for tetraplegia AIS A–C grade injuries.
Seventy-one percent of lifetime costs potentially are paid by the public purse with remaining costs due to reduced
employment and carer time.
Conclusions Despite the magnitude of costs, and being comparable with international estimates, this ﬁrst analysis of SCI
costs in the UK is likely to be conservative. Findings are particularly sensitive to the level and costs of long-term home and
residential care. The analysis demonstrates how modelling can be used to highlight economic impacts of SCI rapidly to
policymakers, illustrate how changes in future patterns of injury inﬂuence costs and help inform future economic evaluations
of actions to prevent and/or reduce the impact of SCIs.
Introduction
The United Kingdom (UK) experiences around 16 new
cases per million population in traumatic spinal cord inju-
ries [1, 2] and 2–3 new cases per million population in non-
traumatic spinal cord injuries per annum [1]. This is >1200
new spinal cord injuries (SCIs) every year, the majority due
to traumatic events, with the remainder resulting from dis-
ease, such as non-malignant tumours.
These SCIs can have devastating, life-changing impacts
on those injured and their families. Economic evaluation
can help make the case for investing in actions to reduce
these injuries, as well as better manage and support people
living with SCI. It can help determine the incremental cost-
effectiveness of actions compared to usual care.
A pre-requisite for any economic evaluation is to quan-
tify the economic costs of SCI to different sectors/stake-
holders. These include National Health Service (NHS) costs
for immediate and ongoing healthcare use, not only in
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dealing with SCI and its many chronic complications,
including pressure sores, respiratory, cardiovascular and
urinary/bowel problems [3], but also treating higher risks of
multi-morbidity, such as depression and obesity [4]. Social
care services, the NHS and people with SCI will also share
rehabilitation, residential and home care costs, including
aids and modiﬁcations. Public employment and education
services will fund reintegration into work or school. Indirect
costs borne by society typically relate to lost employment
and the need for family members to give up their time to
provide informal care.
Despite the importance of economic evidence in health
policymaking in the UK and many countries, there are
surprisingly few estimates of SCI costs. While UK studies
on the cost-effectiveness of interventions for SCI and
complications have been published [5], no detailed
estimates of overall costs of SCI to the healthcare
system, wider public purse and society in a UK
context exist. Indeed, National Institute for Health and
Care Excellence (NICE) guidelines relied on an expert
opinion estimate of £2.5 million in lifetime costs for
spinal injury, with values ranging from £0 to £10 million
[2]. Given this lack of information, we aimed to model
lifetime costs of SCI in the UK. This will also have
broader value, as the model could be adapted to other
country contexts.
Methods
A Microsoft-Excel simulation model estimated net present
value lifetime costs for all new hospital presenting cases of
SCIs in the UK in 1 year. This incidence-based costing
approach is powerful as it allows subsequent economic
evaluations to illustrate potentially avoidable long-term
costs if interventions are effective in preventing and/or
reducing the impacts of any health problem [6]. It has been
used to estimate lifetime costs of SCIs in Australia, Canada
and the US [7–11]. Figure 1 provides an overview of model
structure following presentation to hospital for SCIs. If
individuals survive hospitalisation, including rehabilitation,
they are either discharged home or to residential care. Costs
are incurred over remaining lifespans. The economic ana-
lysis includes immediate and ongoing healthcare costs
directly attributable to SCIs, as well as costs of aids,
adaptations, home modiﬁcations and provision of home-
based and residential care. Unpaid informal care costs and
reduced rates of participation in employment are also
included.
All costs are in 2016 UK pounds, where necessary using
the International Monetary Fund’s World Economic Out-
look Purchasing Power Parity 2016 implied inﬂation and
conversion factors. Costs beyond 1 year are discounted at
the UK HM Treasury Green Book recommended rate of
3.5% per annum.
Incidence data
Given the absence of a single source of UK-wide incidence
data, the model used data from the Queen Elizabeth
National Spinal Injuries Unit (QENSIU). QENSIU
(https://www.spinalunit.scot.nhs.uk/) has treated all new
cases of traumatic SCI in patients aged >12 years in Scot-
land for >20 years [1]. Mean annual incidence rates for
traumatic and non-traumatic paraplegic and tetraplegic SCIs
broken down by gender and 10-year age groups for the
period 2009–2013 were available [1].
In QENSIU, neurological level of injury was assessed by
a spinal injury consultant on admission and deﬁned
according to the International Neurological Classiﬁcation of
Spinal Injury using the American Spinal Injury Association
Impairment Scale (AIS). This economic analysis uses this
data to group traumatic injuries at admission between more
severe AIS-ABC grades for both paraplegia and tetraplegia
and all AIS-D grade injuries. Conservatively, it assumes
that all reported non-traumatic injuries are AIS-D grade
even though at least a third of these injuries could be more
severe and costly [12]. UK Ofﬁce of National Statistics
mid-year age- and gender-speciﬁc population age estimates
for the four UK nations in 2016 were used to calculate the
number of new SCIs nationwide.
Many different approaches have been used to estimate
short- and long-term impacts on mortality of SCIs [13].
Here costs were adjusted to account for 1-year post-injury
mortality rates for paraplegic/tetraplegic AIS-ABC or all
D grades [14]. The model accounts for longer-term sur-
vival by age group, gender and injury severity using a 70-
year study of life expectancy for patients at two English
SCI centres [15].
Resource use and unit costs
Table 1 provides resource use, unit costs and other para-
meters used in the model. Where possible, we made use of
UK sources but otherwise drew on international literature.
We used HRG (Healthcare Resource Groups) tariffs for
costs of immediate hospital episodes for SCI in the
2015–2016 English National Schedule of Reference Costs
[16]. As England represented 84% of the UK population,
we applied these costs UK wide, even though they are
only used for reimbursement in England. This approach is
conservative as some costs in specialist SCI centres may
be higher than these tariffs. Tariffs do not directly dis-
tinguish between traumatic and non-traumatic injuries; we
assume all traumatic SCI events involve an immediate
non-elective hospital stay, plus costs for ambulatory
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transport/treatment. Non-traumatic SCIs conservatively
are assumed to involve an episode of elective hospital
treatment. Costs of excess bed days beyond the maximum
permitted using these tariff codes have been included. We
assumed tetraplegic injuries involve the HC21D tariff for
the higher level of complications and comorbidities (CC)
Score 2+: maximum length of stay of 123 days, beyond
which additional payments are made. Conservatively all
AIS-D grade injuries are valued using a short-stay
tariff used for patients with length of stay of 2 days
maximum.
Rates of rehospitalisation for discharged rehabilitation
patients with SCI can be high, in excess of 50% of patients
with more severe trauma may be readmitted at least once
within 1 year [17–19]. Common reasons for rehospitalisa-
tion include respiratory and urinary tract infections, as well
as fractures; this typically occurs in a local hospital rather
than specialist SCI centre. Specialist centres deal with
highly specialist issues, e.g. pressure sore management,
complex rehabilitation needs or spine surgery. Annual
readmission rates to any hospital following post-
rehabilitation discharge and the number of rehospitalisa-
tions were based on US analysis for specialist rehabilitation
centres, again distinguishing between rates for tetraplegia
and paraplegia ABC grades as well as all D grade injuries
[19]. We have very conservatively used short length of stay
tariffs for all readmissions, even though some stays will be
reimbursed using full tariffs used for initial admissions for
ABC grade injuries. All outpatient consultations were
valued using a non-mandatory English tariff for consultant-
led SCI follow-up consultations, assuming a mean of 1.79
outpatient consultations per annum observed in Denmark
[17]. We also drew on this Danish analysis to estimate 9.94
GP consultations per annum related to SCI.
The need for home/vehicle modiﬁcations depends on
injury severity. A Swiss survey of 482 people with SCI
reported 85% had at least one home adaptation [20], most
commonly a wheelchair-accessible shower (63%). Pub-
lished estimates of adaptation costs vary considerably; we
use estimates from Australian analysis of SCI costs. This
included mean costs for home/transport adaptations, venti-
lation equipment, special beds and communication aids, as
well as vocational equipment, education and training
courses [7]. To be conservative, we only applied these costs
to the ABC grades of tetraplegia and paraplegia.
The model also accounts for immediate/ongoing costs
following discharge to specialist residential care. This is
conservative as the increased likelihood of subsequent
transfer to residential care after 1 year is not included.
Although it is suggested that 20% of UK SCI patients could
Fig. 1 Overview of model structure
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Table 1 Parameters used in model
Description of model parameter Value Unit Source
Non-elective spinal cord injury with CC Score 2+ (HC21D) £20,448.28 Episode (including excess days) [16]
Elective spinal cord injury with CC Score 2+ (HC21D) £10,034.00 Episode (including excess days) [16]
Non-elective spinal cord injury with CC Score 0–1 (HC21E) £6741.14 Episode (including excess days) [16]
Elective spinal cord injury with CC score 0–1 (HC21E) £4305.00 Episode (including excess days) [16]
Non-elective spinal cord injury with CC Score 2+ (short stay)
(HC21D)
£2200.98 Episode [16]
Non-elective spinal cord injury with CC Score 0–1 (short stay)
(HC21E)
£963.17 Episode [16]
Ambulance see, treat and convey (ASS02) £236 Per contact [16]
Non-admitted, face to face consultant led follow- up (WF01A) £289 Per consultation [16]
GP consultation £45 Per consultation [26]
Tetraplegia ABC year 1 modiﬁcations/adaptations £6781 Per person per annum [7]
Tetraplegia ABC year 2 modiﬁcations/adaptations £27,144 Per person per annum [7]
Tetraplegia ABC year 3 modiﬁcations/adaptations £11,935 Per person per annum [7]
Tetraplegia ABC year 4 modiﬁcations/adaptations £6078 Per person per annum [7]
Tetraplegia ABC year 5 modiﬁcations/adaptations £5876 Per person per annum [7]
Tetraplegia ABC year 6 modiﬁcations/adaptations £6527 Per person per annum [7]
Tetraplegia ABC year 7+ modiﬁcations/adaptations £3263 Per person per annum [7]
Paraplegia ABC year 1 modiﬁcations/adaptations £5878 Per person per annum [7]
Paraplegia ABC year 2 modiﬁcations/adaptations £17,178 Per person per annum [7]
Paraplegia ABC year 3 modiﬁcations/adaptations £16,628 Per person per annum [7]
Paraplegia ABC year 4 modiﬁcations/adaptations £8578 Per person per annum [7]
Paraplegia ABC year 5 modiﬁcations/adaptations £8045 Per person per annum [7]
Paraplegia ABC year 6 modiﬁcations/adaptations £5844 Per person per annum [7]
Paraplegia ABC year 7+ modiﬁcations/adaptations £2922 Per person per annum [7]
Tetraplegia ABC rehospitalisation rates in 12 months 44.9 % [19]
Intermediate specialist nursing home care £1294 Per week [23]
High specialist nursing home care £1656 Per week [23]
Very high specialist nursing home care £2277 Per week [23]
Tetraplegia ABC rehospitalisation rates in 12 months 44.9 % [19]
Paraplegia ABC rehospitalisation rates in 12 months 35.3 % [19]
All D grades rehospitalisation rates in 12 months 23.8 % [19]
Tetraplegia ABC average number of rehospitalisations in
12 months
1.45 Mean rehospitalisations [19]
Paraplegia ABC average number of rehospitalisations in
12 months
1.28 Mean rehospitalisations [19]
All D average number of rehospitalisations in 12 months 1.33 Mean rehospitalisations [19]
Mean number of outpatient consultations per annum 1.79 Mean outpatient consultation per person [17]
Mean GP consultations per annum 9.94 Mean GP consultations per person [17]
Discharge rate to nursing homes in 1 year postinjury for all SCI
injuries
6 % [22]
Paraplegia ABC mean hours of professional home care 30.9 Mean hours per week [25]
Tetraplegia ABC mean hours of professional home care 58.1 Mean hours per week [25]
All D mean number of hours of professional home care 5 Mean hours per week Authors’ assumption
Paraplegia ABC mean hours of family home care 16.03 Mean hours per week [7]
Tetraplegia ABC mean hours of family home care 28.0 Mean hours per week [7]
All D mean hours of family home care 4.9 Mean hours per week [24]
Home care (local authority provided) £30.75 Rate per hour [26]
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be discharged to residential care [21], we use a more con-
servative estimate of 6% reported in discharge data from
specialist SCI centres [22]. UK costs for specialist inter-
mediate, high and very high levels of nursing home care are
applied to grade D, paraplegia ABC and tetraplegia ABC
grades, respectively [23]. In the year postinjury, these costs
are adjusted given time already spent in hospital to avoid
double counting. Unit costs used are at the low end of
reported cost ranges; individuals with more complex needs,
e.g. on ventilators, are likely to incur substantially higher
costs than used in the model. The model also does not
account for higher background risk of residential care
admission for older people regardless of SCI status.
The analysis includes costs of long-term home-based
attendant/nursing care. This varies depending on care needs,
from 24-h 7-day-a-week care to little or no care. An eva-
luation of specialist neuro-rehabilitation in the north of
England simply estimated costs for 168 and 14 h per week
care due to lack of data [5]. We identiﬁed analysis where 48
patients 1 year after discharge from a specialist SCI centre
in England received a mean 80 h of paid care per week,
(range 1–168 h) [24]. In all, 63% were classiﬁed as having
paraplegia or tetraplegia AIS grades ABC with the
remainder AIS-D grades at 1 year follow-up.
The model assumes on average individuals with para-
plegia or tetraplegia ABC grades living at home receive
30.87 and 58.1 h of paid care per week, respectively. This is
more conservative than the 80-h per week estimate in the
English analysis we identiﬁed. These values are based on a
breakdown of care use in the United States [25] that we
have reduced to take account of expected informal care
received; for all AIS-D grade injuries, we conservatively
assume a mean of 5 h of contact per week based on our own
expert experience of SCI patients in Scotland. All hours are
costed using hourly rates for local authority provided home
care in England in 2016 [26].
Few estimates of informal family care provided to people
with SCI have been published. We were unable to ﬁnd UK
costs, so we used estimates from Australia on informal care
received by individuals with tetraplegia and paraplegia [7].
There is almost no information on informal care for AIS-D
grade injuries; the model assumed a mean of 1 h per day
based on a small English analysis [24]. As in the Australian
analysis, the model assumed only 70% of SCI cases would
have access to informal care. Costs were valued using the
hourly national minimum wage for the over 25s [27].
Employment rates came from an English survey of 1700
working age people who had used specialist SCI centre
care; only 40.2% of paraplegia ABC injuries and 31.4% of
tetraplegia ABC injuries were employed [28]. This con-
trasts with a 79% employment rate for ‘all working age
people who are not classiﬁed disabled and/or work-limiting
disabled’ [29]. Pain, fatigue and older age are among rea-
sons for reduced employment for AIS-Ds, but data on
actual employment rates is sparse [30]. We assumed 71%
of those of working age would be in employment, using
Canadian analysis [31]. Median annual pay rates from the
UK Annual Survey of Hours and Earnings are used to
Table 1 (continued)
Description of model parameter Value Unit Source
Employment rate for paraplegia ABC 40.2 % [28]
Employment rate for tetraplegia ABC 31.4 % [29]
Employment rate for all D injuries 71.0 % [31]
General employment rate in population without disability
in the UK
79.0 % [29]
Minimum wage over 25s £7.20 Per hour [27]
Annual wage 16 and 17 year olds £6386 Per annum [27]
Median annual wage 18–21 M: £11,283
W: £7695
Per annum [32]
Median annual wage 22–29 M: £22,221
W: £17,796
Per annum [32]
Median annual wage 30–39 M: £29,799
W: £20,488
Per annum [32]
Median annual wage 40–49 M: £33,207
W: £19,319
Per annum [32]
Median annual wage 50–59 M: £31,842
W: £18,572
Per annum [32]
Median annual wage 60–67 M: £23,929
W: £12,832
Per annum [32]
CC complications and comorbidities, GP general practitioner
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value productivity losses for individuals aged 18–67 years
[32], with minimum wage rate used for losses in 16–17-
year olds [27]. This is conservative; individuals aged <16
years will lose educational opportunities, while some aged
>67 years might have remained in the labour market or
otherwise contributed to the economy, such as by volun-
teering or providing care.
Results
The model estimates 1270 (913 male, 357 female) new SCI
cases per annum, of which 13% would be non-traumatic.
Table 2 indicates approximately 35% of SCIs would be
tetraplegia ABC injuries and 18% paraplegia ABC injuries.
Nearly 70% of SCIs are for individuals aged >46 years.
Overall estimated lifetime costs for new cases of SCI are
£1.43 billion (Table 3). More than £60 million of costs are
for the ﬁrst year of care, with 50% of costs incurred by
those aged >56 years (Table 4). In all, 71% of lifetime costs
potentially fall on the public purse and 29% of costs are due
to reduced employment of people living with SCI, as well
family carer time.
Fifty-one million pounds in specialist hospital-based
healthcare service costs is likely to be conservative; these
are greatest for tetraplegia ABC cases, accounting for
>2.9% of their lifetime costs. This ﬁgure does not include
further substantive costs in hospital/home for the most
complex cases of SCI, including ventilation. Anecdotally,
we are aware of annual costs in excess of £320,000 per
annum for 24/7 home care for a person with SCI requiring
ventilation.
Figure 2 illustrates mean expected lifetime costs per
SCI case. Overall, costs would be £1.12 million per SCI,
ranging from £0.47 million per person with grade D
injuries to £1.87 million per tetraplegia ABC injury.
Mean lifetime costs per woman are higher: £1.15 million
versus £1.11 million per man. Median lifetime costs
per SCI of £0.72 million are lower reﬂecting the con-
centration of injuries in older age groups. Median costs
range from £0.40 million per grade D injury to £1.95
million per tetraplegia ABC injury. Median lifetime costs
per woman are higher: £0.80 million versus £0.72 million
per man.
Sensitivity analyses
Sensitivity analyses explored impacts of changing key
model assumptions. The maximum initial tariff for non-
elective traumatic complex spinal injuries used was
£20,448, with much lower tariffs used for less severe
injuries; even with rapid transfer to specialist SCI centres,
care costs for some can be much higher, especially if
requiring long-term ventilation. A French study reported
6.5% of new traumatic SCI cases required long-term ven-
tilation [33]. If 6.5% of all traumatic tetraplegia cases
required ventilation, with mean 60-day stay in a specialist
centre at £981 per day [34] their individual costs would
increase to £58,860 and lifetime mean costs for all tetra-
plegia ABC grades increase from £1.870 million to £1.873
million. Overall costs of SCI would rise marginally to
£1.428 billion from £1.427 billion. If 20% of tetraplegia
cases required ventilation, costs would rise to £1.431 billion
overall and £1.878 million per tetraplegia ABC case. The
model thus appears relatively insensitive to increasing
immediate healthcare costs associated with the most trau-
matic cases, although additional costs of complications,
such as dealing with pressure sores and infections, are not
included. We conservatively used short-stay HRG tariffs for
grade D injuries and rehospitalisations for ABC grade
injuries. The model is more sensitive to changes in this
assumption. For each additional 10% of D injuries and all
ABC rehospitalisations that required a longer stay (quali-
fying full tariff reimbursement), overall costs increased by
£13 million.
The model is sensitive to professional home care
assumptions. If all individuals with tetraplegia ABC injuries
received 7.3 home care hours per day (less informal care
time) rather than 12.3 h per day, then overall costs fall to
£1.11 billion and mean lifetime costs per individual with
tetraplegia ABC injuries to £1.15 million. If total hours of
professional care are not reduced to take account of
expected mean informal care received, costs increase to
£1.78 billion. If the 6.5% of people with tetraplegia ABC
who might require long-term ventilation were also to need
24-hour daily home care, then total lifetime costs would rise
to £1.83 billion, with mean lifetime costs per tetraplegia
ABC case increasing to £2.56 million.
The home care hourly rate also impacts on care costs. If a
lower hourly rate for personal care of £14.28 [26] is used,
then overall costs of SCIs fall to £1.18 billion. The model is
also sensitive to assumptions on use of long-stay residential
care. If 20% (rather than 6%) of tetraplegia and paraplegia
ABC cases were discharged from hospital to residential care
[21], then overall costs increase to £1.80 billion, with mean
lifetime costs of £2.48 million and £1.85 million,
respectively.
Discussion
An incidence-based costing approach provides policy-
makers with information on long-term impacts; new UK
cases of SCI per annum may incur lifetime costs exceeding
£1.43 billion or £1.12 million per case, with more than two
thirds of costs potentially falling on the public purse.
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This estimate is conservative. For instance, £21.4 mil-
lion is spent annually on spinal cord rehabilitation services
in England (HRG code VC08Z) [22], but we do not know
the proportion for new SCI cases. We have not included
additional costs for treatment/management of speciﬁc
complications or multi-morbidities, including any support
from mental health specialists. In Australia, initial hospi-
talisation costs for those aged >65 years who experienced
traumatic SCI were 30% higher (mean difference £3611)
than for the under 65s due to greater co-morbidities [35].
Nor does it include lifetime costs of essential drug therapies
or ventilator dependence. We omit costs associated with
delays in reaching specialist SCI units from critical care
settings, as well as avoidable delayed discharges from
specialist settings due to limited suitable accommodation
[34]. We omit adverse impacts on quality of life or
social exclusion that substantially increase societal costs.
Our estimate of non-traumatic SCI cases is probably
conservative, based on attendance at one specialist SCI
centre, as some less severe cases may not be referred to
these services. We have not captured costs of treatment
activity for non-traumatic SCI related to underlying mor-
bidities, such as vascular disorders or malignancies, where
these costs are reimbursed under a different HRG tariff.
Furthermore, we assumed a high employment rate for AIS-
D cases (71%), but little is known on actual employment
rates, nor does our model account for return to part-time
rather than full-time work.
International studies point to substantive costs but esti-
mates vary greatly and interpretation is difﬁcult due to
differences in health/social care systems. Studies use a
variety of methodologies, deﬁne SCIs in different ways and
focus on different elements of cost. Few include non-
traumatic SCIs.
Several used incidence-based costing approaches. A
model for traumatic SCIs in Australia reported lifetime costs
Table 2 Estimated new cases of
SCI in the UK in 2016
Age group, years Paraplegia—
ABC
Tetraplegia—
ABC
All D Total Percentage of
total cases
0–15 3 6 6 16 1.27%
16–25 24 48 59 131 10.31%
26–35 22 43 53 118 9.30%
36–45 22 43 67 132 10.38%
46–55 41 80 116 237 18.67%
56–65 40 79 118 237 18.63%
66–75 44 86 119 249 19.57%
76–85 26 50 58 133 10.50%
86+ 4 7 7 17 1.36%
Total 225 442 603 1270
Percentage of total cases 17.69% 34.80% 47.51%
SCI spinal cord injury
Table 3 Lifetime costs of new
spinal cord injuries in the UK in
2016 (£s 2016 prices)
All Paraplegia—
ABC
Tetraplegia—
ABC
All D Total cost
Immediate inpatient care costs 1,561,340 9,141,768 1,085,259 11,788,367
Initial home and vehicle
modiﬁcations
1,259,756 2,680,908 0 3,940,665
Ongoing home modiﬁcations 20,018,649 32,834,814 0 52,853,463
Ongoing healthcare costs 5,822,627 14,925,680 18,360,452 39,108,759
Initial home care costs 4,972,049 17,262,371 2,202,335 24,436,755
Ongoing home care costs 179,650,347 511,312,375 93,463,185 784,425,907
Initial residential care costs 553,653 1,404,319 1,183,112 3,141,083
Ongoing residential care costs 20,004,608 41,595,991 50,209,180 111,809,779
Initial family care costs 604,532 1,947,914 505,355 3,057,802
Ongoing family care costs 21,843,002 57,697,312 21,467,517 101,007,831
Productivity losses 59,912,035 135,729,880 96,014,860 291,656,775
Total 316,202,599 826,533,331 284,491,256 1,427,227,187
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of £2.73 million and £5.2 million per paraplegia or tetra-
plegia case, respectively. These costs are higher than our
analysis (£1.41 million and £1.87 million, respectively),
mainly because the Australian model includes the monetary
value for lost quality of life due SCI disability. It estimated
that each year of full quality life lost would cost £91,750
[7]. These costs are not borne by the public purse and the
values are open to challenge; in the UK values between
£20,000 and £30,000 per year of full quality life are typi-
cally used [2]. Excluding these costs and looking solely at
health, long-term care, aids and adaptations, lifetime costs
in the Australian model for paraplegia and tetraplegia were
£1.11 million and £2.77 million, respectively. Remaining
differences are due to Australian inclusion of some costs of
treating multi-morbidities, as well as not accounting for the
lower costs of D grade injuries.
A Canadian model estimated lower lifetime costs
(including quality-of-life losses valued at £28,841 per year)
between a mean £0.89 million for incomplete paraplegia to
£1.82 million for complete tetraplegia [8]. This is mainly
due to much lower assumed costs for residential care.
Another Canadian study reported net lifetime healthcare
costs per traumatic SCI case compared to a matched
population without SCI. Incremental costs were between
£0.14 million and £0.28 million, depending on rehabilita-
tion and pre-existence of pressure ulcers [9]. Gross lifetime
costs, not deducting non-SCI healthcare costs, were mod-
estly higher, ranging from £0.17 million to £0.31 million.
In a US model health, rehabilitation and long-term care
mean lifetime costs were between £0.58 million and £4.20
million depending on age and injury severity [10]. In
another, mean lifetime all-cause hospital costs for thoracic
SCI were calculated using data from 14 specialist SCI
centres [11]. Costs were £0.23, £0.18, £0.13 and £0.05
million for each AIS grade A–D, respectively. This study
did not include health, long-term care or rehabilitation costs
outside of hospital.
In our analysis, mean initial year costs per case for
hospitalisation, aids and adaptation, as well as any resi-
dential or home care use, were £39,846, £73,393 and
£8,246 for paraplegia ABC, tetraplegia ABC and AIS-D,
respectively. In Australia, mean initial costs of hospitalisa-
tion for traumatic SCI, including initial rehabilitation as
well as acute care, were estimated as £11,652 and £15,264
Fig. 2 Mean lifetime costs of new spinal cord injuries by type and gender (2016 £ millions)
Table 4 Total costs by age group in initial year of SCI in the UK in
2016 (£s 2016 prices)
Age
group, years
Paraplegia—
ABC
Tetraplegia
—ABC
All D Total cost
0–15 135,574 488,925 63,734 688,232
16–25 1,130,947 3,910,368 758,369 5,799,684
26–35 1,209,899 3,953,977 966,054 6,129,930
36–45 1,245,033 4,033,442 1,268,831 6,547,306
46–55 2,285,565 7,429,094 2,173,540 11,888,199
56–65 2,162,988 7,110,349 2,058,266 11,331,603
66–75 2,312,026 7,648,383 2,007,549 11,967,958
76–85 1,053,393 3,798,898 569,262 5,421,553
86+ 145,624 525,169 68,459 739,251
Total cost 11,681,047 38,898,605 9,934,063 60,513,715
SCI spinal cord injury
D. McDaid et al.
for individuals aged up to 64 and aged ≥65 years, respec-
tively [35]. Costs in the Australian analysis varied drama-
tically depending on type of injury with mean total hospital
costs for sub-groups of individuals ranging from £5353 for
mild-to-moderate injuries for the younger cohort compared
with £19,956 for serious injuries for the older cohort. In
Canadian analyses, mean initial year hospital costs for
traumatic SCI cases covering health, rehabilitation and
continuing care were £72,496 [9] and £75,192 [36]. Costs
for complete SCI of £92,283 and £31,950 for incomplete
SCI were also reported [37]. In Spain, ﬁrst year costs of SCI
due to motor vehicle trauma (MVT) or all other causes were
modelled [38]. Average healthcare costs, adaptations and
specialist ongoing care for the MVT and non-MVT groups
were £31,092 and £30,593, respectively.
We conclude that, despite the magnitude of costs, this
ﬁrst analysis of UK SCI costs is conservative. Further
analyses of UK costs, making use of registry data on long-
term resource use, are needed. This would allow analysis to
account for SCIs converting from one ASIA grade to
another [39]. Work is also needed worldwide to better
understand non-traumatic SCI costs. Our model could be
adapted and further developed as these data become
available.
Our analysis shows how models play a powerful role in
highlighting economic impacts of SCI to policymakers and
illustrating how changes in patterns of cause, type, age at
injury and mortality risk inﬂuence future costs. This is
important given trends towards higher age at injury, for
instance linked to falls rather than trafﬁc accidents. In our
model, age at injury substantially impacts on costs, for
instance with mean lifetime cost of traumatic tetraplegia in a
man aged 36–45 years being £2.63 million compared with
£1.30 million if aged between 56 and 65 years (Fig. 3), but
as Table 4 illustrates 49% of aggregate costs for the ﬁrst
year of treatment are incurred by those aged >56 years.
Models are vital tools in bringing together estimates of SCI
costs with evidence on effective ways of improving
outcomes at individual and population level. They help
provide evidence on key policy concerns to be addressed,
including the economic case for improved care pathways,
prompt referral to specialist SCI centres and reductions in
delayed discharges following rehabilitation. Our model also
implies a case for evaluating the long-term cost-effective-
ness of rehabilitation programmes. If effective in improving
compensatory skills and helping SCI patients to use devices
that maximise functional performance, then substantive
lifetime costs to the public purse and families may be
averted.
Data archiving
The Excel model used to estimate these costs is available on
request from the corresponding author. It is also available to
download from https://www.spinal-research.org/cost-spina
l-cord-injury.
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